SIRION Biotech develops viral vectors and engineered cell models for functional genomics, target validation, and cell and gene therapy research. Its scientists optimize adenoviral, lentiviral, and adeno-associated viral systems, including capsid selection, vector design, production, and testing for difficult cells or tissues. Custom solutions help researchers improve gene delivery, create stable or inducible cell lines, and establish more predictive assays before moving to therapeutic-scale development.
SIRION Biotech
SIRION Biotech, a PerkinElmer company, is a global leader in viral vector technology, specializing in the custom design and manufacturing of high-quality adenoviral, lentiviral, and AAV vectors. Serving the cell and gene therapy industries, SIRION guides developers from early-stage target validation through complex vector optimization to maximize therapeutic delivery efficiency.
